glp 1 anxiety and depression Association between GLP-1 receptor agonist use worsening mental illness in people with and in Sweden: a national cohort study Depression: Oranges, exercise, and GLP-1

With this improved financial foundation, the company was well equipped to execute its transformation plan, which includes innovating its digital and member experience and accelerating the expansion of its telehealth business which delivered 57% year-over-year revenue growth in Q1 2025, said WeightWatchers

Victims are allowed until February 9th, 2026 to provide rebuttal expert reports

Leptin resistance is not a formal clinical diagnosis in UK practice, and routine leptin measurement is not recommended to guide GLP-1 agonist therapy

Inc., Sanofi here News-ID: 4482091 Views: More Releases from DataM Intelligence 4 Market Research LLP United States Multiple Myeloma Market 2035 | Growth Drivers, Trends & Market For Market Size and Growth 2026 The Multiple Myeloma Market is estimated at approximately US$ 23.55 billion in 2025 and is expected to reach approximately US$ 40.88 billion by 2035 and is projected to grow at a CAGR of 5.6% during the forecast period 2026-2035 DataM Intelligence has released a new research report titled Multiple Myeloma Market Size 2026 The report delivers in-depth insights into key market dynamics, including regional growth trends, market Immersive Technologies Market Size, Growth Analysis & Future Outlook 2026-2033 | The global Immersive Technologies market was valued at USD 38.14 billion in 2025 and is projected to reach USD 142.68 billion by 2033, expanding at a CAGR of 16.8% during the forecast period from 2026 to 2033